A-B. RPE (A) and U2OS (B) cells were induced with 100 ng/mL and 300 ng/mL NCS, respectively, for 30 minutes, and pulsed with 10 µM EdU for 15 minutes before fixation. The cells were then stained for γH2AX and DAPI to quantify the level of DSBs and DNA content, respectively. The cell cycle phase was designated based on the EdU and DAPI intensity. ns indicates no significant difference, based on the significance level of p=0.05 using Kolmogorov-Smirnov test.
C-D. RPE (C) and U2OS (D) cells that were damaged in S and G2-M were quantified for the fractions of being arrested in G2-M by the end of 48hr hour post damage. The p-values were calculated based on Fisher's exact test.
E-F. RPE (E) and U2OS (F) cells that were damaged in S and completed the subsequent G2-M were quantified for the G2-M durations. Control represents cells without NCS treatment. Error bars represent standard deviations.
G-H. Measuring the fate of cells damaged in S phase. RPE (G) and U2OS (H) cells were treated with NCS of indicated concentrations for 5 mins, followed by a pulse of 10 μM EdU for 25 mins, and then washed out with fresh media. The cells were then incubated for 20 hours to allow for cell cycle progression before fixation, staining, and quantification for EdU incorporation and DAPI content. The cells in the control were not treated with NCS and were pulsed with 25 minutes of EdU right before fixation to reveal the cell cycle distribution in unperturbed cells. The colors represent the density of data points: yellow, high density; blue, low density. (n ranges from 1300 to 5000) I-K. Cell cycle phase-specific transition curves in response to zeocin damage in U2OS cells. Transition curves for asynchronously dividing U2OS cells treated with either a 10-minute pulse of zeocin at 500 µg/mL and 1000 ug/mL or sustained zeocin at 250 µg/mL during (I) G1, (J) S, or (K) G2-M. The pulse treatment was used to generate the transient DNA damage effect as NCS. The sustained treatment was used to generate long-term DNA damage. A-C. Cell cycle phase-specific transition curves in response to acute DNA damage in RPE cells. Upper panels and solid lines: As in Figure 3A -B, transition curves for asynchronously dividing RPE treated with NCS at the indicated concentrations during (A) G1, (B) S, or (C) G2-M. Lower panels and dashed lines: Best fit lines of the experimental data to the "arrest-and-restart" DNA damage checkpoint model described in Figure 1A . A-B. Model fitting of cell cycle phase-specific transition curves in response to acute DNA damage, as in lower panels of Figure S3A -F, but fit with the refined model that incorporated both the flexible commitment point location and the possibility of graded slowdown checkpoint kinetics. Each condition was fit with the (A) graded slowdown or (B) all-or-none checkpoint kinetics.
C. Commitment point estimation by resampling half of the transition data. The transition time points for RPE's G1 transition curve under 100 ng/mL NCS treatment were repeatedly and randomly drawn using half of the data points (n=51) and were fitted with the refined all-or-none checkpoint model. Estimated parameters that produced a simulated transition curve with a mean square error less than 0.2 from the experimental data were recorded (n=294).
D. Same as C, but with U2OS's G1 transition curve under 300 ng/mL NCS and half sample size of 31. Estimated parameters that produced a simulated transition curve with a mean square error less than 0.25 from the experimental data were recorded (n=181).
E. Commitment point estimation by repeated fitting using all of the transition data. The transition time points for RPE's G1 transition curve under 100 ng/mL NCS treatment were repeatedly fitted with the refined all-or-none checkpoint model. Estimated parameters that produced a simulated transition curve with a mean square error less than 0.2 from the experimental data were recorded (n=166).
F. Same as E, but for U2OS's G1 transition curve under 300 ng/mL NCS. Estimated parameters that produced a simulated transition curve with a mean square error less than 0.25 from the experimental data were recorded (n=126). A. By fitting the data with the "arrest-and-restart" model, we estimated the halt durations in G1 and G2-M in response to the indicated NCS concentrations.
B. Same as A, but the data were fitted with the refined model with a flexible commitment point.
C. By fitting the data with the "arrest-and-restart" model, we estimated the permanent arrest probabilities in G1 and G2-M in response to the indicated NCS concentrations. D. Same as C, but the data were fitted with the refined model with a flexible commitment point. E-F. RPE cells damaged in (E) G1 and (F) G2-M that eventually transitioned to the next phase were quantified for the probability of being arrested in the subsequent phases by the end of the 48-hour experiment. The probability of permanent arrest in a given phase was conditioned on the cells that had entered that given phase. The "x" symbols indicate 0% permanent arrest. O. Mitosis durations based on nuclear envelope breakdown revealed by both the DIC and mCherry channels under basal conditions. The error bars represent standard error of mean (RPE: n=31 (25 ng/mL), 4 (50 ng/mL), 3 (100 ng/mL). U2OS: n>32 in all conditions). P-Q. Asynchronous RPE (P) and U2OS (Q) cells were treated with the indicated concentrations of NCS. After 60 minutes, cells were fixed, stained, and quantified for γH2AX foci. The data were fitted with a linear regression. The error bars represent standard error of the mean. R-S. RPE (R) and U2OS (S) cells were treated with the indicated NCS concentrations and followed for phase transitions. The total G2-M durations of those that were prolonged were plotted against the time spent in G2-M before damage. The data were fitted with a linear regression. The data for RPE under 50 ng/mL and 100 ng/mL were not fitted with linear regression separately, due to the small sample size. A-B. Simulation of cell cycle phase duration produced the 95 percentile cell cycle. Simulation parameters were obtained from the untreated controls' cell cycle phase durations of (A) RPE and (B) U2OS, fitted with the Erlang distribution. Each point represents a single simulated cell, and the colors represent the density of data points. The red dashed lines represent the top 95 percentile of the total S phase duration for a given time spent in that phase at damage. Figure S6A -B were superimposed onto these plots. This analysis allows for the designation each cell into the three outcome categories (unaffected, temporary arrest, and permanent arrest), as in Figure 5B . PA indicates permanent arrest. A. Simulations of cell cycle phase durations as a function of time spent in that phase before damage. Simulations were performed using the fitted parameters (the shape, k, and scale, 1/λ) from RPE's G1 (upper panels) and S phase (lower panels) distributions to represent a phase duration with large variance and small variance, respectively. In the cases with all-or-none checkpoint kinetics, the delay duration was 8 hours. In the cases of graded slowdown checkpoint kinetics, the slowdown factor was 0.5. In the cases of an internal commitment point, the location was 75% of the entire phase from the onset of the phase.
G-H. RPE cells damaged in (G

C-H. The total cell cycle phase durations of RPE (C, E, G) and U2OS (D, F, H) cells were plotted against the time spent in that phase at the time of damage. The 95 percentile lines (red dashed lines) obtained from
B-D. Experimental data of the total S phase durations as a function of time spent in S phase before damage. Data were from RPE (B) and U2OS (C-D) cells treated with NCS concentrations high enough to affect the total S phase durations. Red lines represent linear regression of the experimental data. Blue dash lines represent the model predictions of the mean S phase durations based on the graded slowdown checkpoint kinetics. E. Cell cycle outcome's dependency on the stage of cell cycle phase progression, as in Figure 6C . Cell cycle outcomes are plotted as a function of cell cycle phase stage-early, mid, and late stages. Early, mid, and late stages were categorized based on thresholds defined by the 33 and 67 percentiles of time spent in a phase at the time of damage. Fraction change relative to control was obtained by calculating the difference between the fraction of cells being affected (either temporary or permanent arrest) under NCS treatment and that without NCS treatment. The construction of such cell cycle phase stage plot in RPE's G2-M could not be performed due to the short length of G2-M duration and sparsity of cells (see Figure S6G) . The increased affected fraction in late G1 stage can be explained by sampling bias, such that cells categorized as late stage were possibly already activating arrest response before NCS treatment. Therefore, there is a strong dependency of total duration on the stage during which the cell is sampled, as seen in Figure S6B left panel. Table S1 . Related to Figure 3. Fitting parameters for the "arrest-and-restart" checkpoint model reveal  dependencies of halt duration and permanent arrest probability on 
